Elucidating the exact pharmacological system of action (MOA) of Normally transpiring compounds can be hard. Even though Tarselli et al. (60) made the main de novo artificial pathway to conolidine and showcased that this naturally happening compound successfully suppresses responses to both of those chemically induced and inflammation-derived pain,